Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

A compound, a stereoisomeric form thereof, or a physiologically acceptable salt thereof, of the formula XIII:

• wherein:
• A1 is phenylene which is unsubstituted or substituted by one or more identical or different substituents chosen from halogen, (C1-C4)-alkyl, CF3, —O—(C1-C4)-alkyl, and —CN;
• A2 is a benzene ring;
• R1 is NR5R6;
• R3 is one or more identical or different residues chosen from hydrogen, halogen, CF3, —O—(C1-C4)-alkyl, —CN, and (C1-C4)-alkyl;
• R5 and R6 together with the nitrogen atom to which they are bonded form a 5-membered or 6-membered saturated heterocycle, wherein said heterocycle optionally further comprises an additional ring heteroatom chosen from nitrogen, oxygen, and sulfur, and said heterocycle is unsubstituted or substituted by one or more identical or different residues chosen from (C1-C3)-alkyl, hydroxy-(C1-C3)-alkyl-, aryl, carbamoyl, hydroxy, and oxo;
• aryl is phenyl or 5-membered or 6-membered heteroaryl comprising one or more identical or different ring heteroatoms chosen from nitrogen, oxygen, and sulfur, and is unsubstituted or substituted by one or more identical or different substituents chosen from halogen, (C1-C4)-alkyl, CF3, NO2, —O—(C1-C4) alkyl —NH—CO—(C1-C4)-alkyl, and —CN;
• n is 2;
• and
• X is oxygen;